Monoamine oxidase inhibitory activity in tobacco smoke varies with tobacco type

被引:26
|
作者
Lewis, Amy J. [1 ,2 ]
Truman, Penelope [1 ]
Hosking, Matthew R. [1 ]
Miller, John H. [2 ]
机构
[1] Inst Environm Sci & Res Ltd, Porirua, New Zealand
[2] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand
关键词
D O I
10.1136/tc.2010.040287
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background It has been suggested that inhibition of monoamine oxidase (MAO) activity by components of cigarette smoke may impact on smoking addiction, but it is unclear to what extent the known MAO inhibitors in tobacco smoke cause this inhibition. Methods MAO inhibitory activity was measured in a series of tobacco particulate matter preparations from different brands of cigarette and loose-leaf tobacco commonly available in New Zealand. Results When tobacco extracts were diluted to contain a physiologically relevant nicotine concentration of 0.2 mu M, all samples tested inhibited MAO-A and MAO-B by between 4% and 12% in a standard assay. Per mg of nicotine, samples from factory-made cigarettes contained significantly less MAO inhibitory activity than did samples from loose-leaf tobacco. When inhibitory activity was calculated on a per mg of tar basis, there was no significant difference between loose-leaf tobaccos and factory-made cigarettes. Conclusions The present study shows that the ratio of nicotine to MAO inhibitory activity varies depending on the type of tobacco product used. The roll-your-own tobaccos tested delivered more tar and more MAO inhibitory activity per mg of nicotine than the factory-made cigarettes. These findings suggest that smokers of roll-your-own tobacco may experience greater difficulty in stopping smoking.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 50 条
  • [1] Inhibition of monoamine oxidase by tobacco smoke
    Castagnoli, K
    Fourie, I
    Van der Schyf, CJ
    Murugesan, T
    Castagnoli, N
    CHEMICAL RESEARCH IN TOXICOLOGY, 2002, 15 (12) : 1664 - 1664
  • [2] A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke
    Hong, Sa Weon
    Teesdale-Spittle, Paul
    Page, Rachel
    Truman, Penelope
    NEUROTOXICOLOGY, 2022, 93 : 163 - 172
  • [3] On the inhibition of monoamine oxidase by tobacco smoke.
    Castagnoli, K
    Fourie, I
    Van der Schyf, CJ
    Murugesan, T
    Castagnoli, N
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U370 - U370
  • [4] Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase
    Castagnoli, Kay
    Steyn, Stefanus J.
    Magnin, Geraldine
    Van der Schyf, Cornelis J.
    Fourie, Izel
    Khalil, Ashraf
    Castagnoli, Neal
    NEUROTOXICITY RESEARCH, 2002, 4 (02) : 151 - 160
  • [5] Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase
    Kay Castagnoli
    Stefanus J. Steyn
    Geraldine Magnin
    Cornelis J. Van Der Schyf
    Izel Fourie
    Ashraf Khalil
    Neal Castagnoli
    Neurotoxicity Research, 2002, 4 : 151 - 160
  • [6] Monoamine oxidase inhibitory activity of a series of adducts of 1,2,3,4-tetrahydroisoquinoline and tobacco smoke
    MendezAlvarez, E
    SotoOtero, R
    SanchezSellero, I
    Lamas, MLR
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S53 - S53
  • [7] Monoamine oxidase and tobacco dependence
    Lewis, A.
    Miller, J. H.
    Lea, R. A.
    NEUROTOXICOLOGY, 2007, 28 (01) : 182 - 195
  • [8] Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke
    Khalil, AA
    Davies, B
    Castagnoli, N
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (10) : 3392 - 3398
  • [9] Monoamine oxidase inhibition for tobacco pharmacotherapy
    George, T. P.
    Weinberger, A. H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (04) : 619 - 621
  • [10] Monoamine oxidase inhibitory activity in tobacco particulate matter: Are harman and norharman the only physiologically relevant inhibitors?
    Truman, Penelope
    Grounds, Peter
    Brennan, Katharine A.
    NEUROTOXICOLOGY, 2017, 59 : 22 - 26